$18.41 Million in Sales Expected for Sharps Compliance Corp. (NASDAQ:SMED) This Quarter

Brokerages expect Sharps Compliance Corp. (NASDAQ:SMED) to post sales of $18.41 million for the current quarter, according to Zacks. Four analysts have issued estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $19.30 million and the lowest estimate coming in at $17.50 million. Sharps Compliance reported sales of $17.01 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 8.2%. The firm is scheduled to announce its next quarterly earnings report on Thursday, January 27th.

On average, analysts expect that Sharps Compliance will report full-year sales of $65.83 million for the current year, with estimates ranging from $62.20 million to $68.50 million. For the next year, analysts expect that the firm will report sales of $69.77 million, with estimates ranging from $68.01 million to $71.10 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Sharps Compliance.

Sharps Compliance (NASDAQ:SMED) last released its quarterly earnings data on Tuesday, October 26th. The industrial products company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). The business had revenue of $13.92 million for the quarter, compared to the consensus estimate of $13.49 million. Sharps Compliance had a return on equity of 22.68% and a net margin of 16.03%. During the same period in the previous year, the business posted ($0.02) earnings per share.

A number of equities research analysts recently issued reports on the stock. HC Wainwright reiterated a “hold” rating on shares of Sharps Compliance in a research report on Thursday, October 28th. Barrington Research restated an “in-line” rating on shares of Sharps Compliance in a research report on Wednesday, November 3rd. Finally, Zacks Investment Research upgraded shares of Sharps Compliance from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 28th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $17.50.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Morgan Stanley grew its holdings in Sharps Compliance by 244.7% during the second quarter. Morgan Stanley now owns 603,414 shares of the industrial products company’s stock worth $6,215,000 after purchasing an additional 428,350 shares during the period. Goldman Sachs Group Inc. grew its holdings in Sharps Compliance by 344.1% during the third quarter. Goldman Sachs Group Inc. now owns 492,407 shares of the industrial products company’s stock worth $4,072,000 after purchasing an additional 381,522 shares during the period. Sanders Morris Harris LLC bought a new position in Sharps Compliance during the third quarter worth about $2,734,000. Polar Asset Management Partners Inc. bought a new position in Sharps Compliance during the third quarter worth about $2,078,000. Finally, Deutsche Bank AG grew its holdings in Sharps Compliance by 2,164.5% during the second quarter. Deutsche Bank AG now owns 229,233 shares of the industrial products company’s stock worth $2,362,000 after purchasing an additional 219,110 shares during the period. Institutional investors own 47.79% of the company’s stock.

Shares of NASDAQ:SMED traded up $0.06 during midday trading on Thursday, reaching $7.74. 63,795 shares of the company’s stock were exchanged, compared to its average volume of 183,306. The company’s 50 day simple moving average is $8.12 and its two-hundred day simple moving average is $9.97. The firm has a market capitalization of $148.83 million, a PE ratio of 10.75 and a beta of -0.28. Sharps Compliance has a 12 month low of $7.39 and a 12 month high of $18.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.36 and a current ratio of 3.82.

Sharps Compliance Company Profile

Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX.

See Also: What are economic reports?

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.